A low dose of SD70 (500 nM) efficiently suppressed proliferation (Figure 6J) and induced differentiation (Figure 6K) of primary AML cells carrying MLL fusions (i.e., MLL1-3) but not the control primary AML primary cells without the translocations (non-MLL1-4). Here, KMT2A is linked to acute myeloid leukemia.